Apstatin - Moligand™, ≥95% , Inhibitor of X-prolyl aminopeptidase 1;Inhibitor of X-prolyl aminopeptidase 2, CAS No.160470-73-5, Inhibitor of X-prolyl aminopeptidase 1;Inhibitor of X-prolyl aminopeptidase 2
Apstatin - Moligand™, ≥95% , Inhibitor of X-prolyl aminopeptidase 1;Inhibitor of X-prolyl aminopeptidase 2, CAS No.160470-73-5, Inhibitor of X-prolyl aminopeptidase 1;Inhibitor of X-prolyl aminopeptidase 2
グレード&純度Moligand™?Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools.≥95%
Synonyms
1-[1-(3-Amino-2-hydroxy-4-phenylbutanoyl)prolyl]-N-(1-hydroxy-1-iminopropan-2-yl)pyrrolidine-2-carboximidic acid|N-[(2S,3R)-3-AMINO-2-HYDROXY-4-PHENYL-BUTANOYL]-L-PROLYL-L-PROLYL-L-ALANINAMIDE|N-[(2s,3r)-3-amino-2-hydroxy-4-phenylbutanoyl]-l-prolyl-l-prolyl-l-alaninamide|Apstatin|Aminopeptidase P Inhibitor|(2S)-1-[(2S)-1-[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl]pyrrolidine-2-carbonyl]-N-[(2S)-1-amino-1-oxopropan-2-yl]pyrrolidine-2-carboxamide|L-Alaninamide, 1-[(2S,3R)-3-amino-2-hydroxy-1-oxo-4-phenylbutyl]-L-prolyl-L-prolyl-|L-ALANINAMIDE, 1-((2S,3R)-3-AMINO-2-HYDROXY-1-OXO-4-PHENYLBUTYL)-L-PROLYL-L-PROLYL-|N-((2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl)-L-prolyl-L-prolyl-L-alaninamide|1-[1-(3-Amino-2-hydroxy-4-phenylbutanoyl)pyrrolidine-2-carbonyl]-N-(1-amino-1-oxopropan-2-yl)pyrrolidine-2-carboxamide|(S)-1-[(S)-1-((2S,3R)-3-Amino-2-hydroxy-4-phenyl-butyryl)-pyrrolidine-2-carbonyl]-pyrrolidine-2-carboxylic acid ((S)-1-carbamoyl-ethyl)-amide|(S)-N-((S)-1-Amino-1-oxopropan-2-yl)-1-((S)-1-((2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl)pyrrolidine-2-carbonyl)pyrrolidine-2-carboxamide
Apstatin is a selective inhibitor of aminopeptidase P (APP), with a K|i|of 2.6 μM in rat lung membrane-bound APP. Apstatin is shown to increase Bradykinin-promoted cardioprotection in rats with artificially introduced myocardial infarctions by inhibiting the Bradykinin degradation action of APP. When combined with the angiotensin-converting enzyme inhibitors enalapril , lisinopril , or ramipril , decrease of myocardial infarction size was enhanced.
This compound belongs to the class of organic compounds known as hybrid peptides. These are compounds containing at least two different types of amino acids (alpha, beta, gamma, delta) linked to each other through a peptide bond.
External Descriptors
Not available
1. Djoumbou Feunang Y, Eisner R, Knox C, Chepelev L, Hastings J, Owen G, Fahy E, Steinbeck C, Subramanian S, Bolton E, Greiner R, and Wishart DS. ClassyFire: Automated Chemical Classification With A Comprehensive, Computable Taxonomy. Journal of Cheminformatics, 2016, 8:61.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.